Leidos raises FY26 adjusted EPS guidance to $12.50-$12.70
Leidos Holdings Inc. raised its FY26 adjusted EPS guidance to $12.50-$12.70 from $12.20-$12.50, citing improved profitability. Sales guidance was lowered to $18.000B-$18.200B from $18.200B-$18.400B due to the SES joint venture. Operating cash flow was increased to ~$1.90B from ~$1.85B. Q2 revenue grew 7% YoY to $4.56B, with record operating cash flow of $793M.
How this was made

The 30-second read
Why it matters
The EPS upgrade may trigger short covering and buying from analysts who had lower expectations.
Market read
First report of Leidos' FY26 EPS raise, a material earnings update that can move the stock.
What to watch
Potential headwinds in the Health segment and the SES joint venture impact on revenue.
Background
Leidos disclosed FY26 guidance updates alongside Q2 FY26 results, highlighting segment performance and cash flow.
Ticker impact
Leidos raised FY26 adjusted EPS guidance to $12.50‑$12.70, above analyst estimate of $12.40.
upside pressure as market prices in higher earnings expectations
EPS guidance exceeds consensus while revenue outlook is modestly lower, indicating margin expansion.
Market effects
Defense and homeland contractors may see relative strength as Leidos signals margin expansion.
U.S. defense sector could benefit from positive earnings outlook.
Limited to investors tracking U.S. aerospace & defense equities.
Counterpoint
Revenue guidance miss could weigh on the stock if investors prioritize top‑line growth over margins.
Key entities
- companyLeidos Holdings Inc
U.S. defense and technology contractor reporting FY26 guidance.

